Filing Details

Accession Number:
0001237899-12-000024
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-15 16:52:25
Reporting Period:
2012-02-13
Filing Date:
2012-02-15
Accepted Time:
2012-02-15 16:52:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226689 Neil Stahl 777 Old Saw Mill River Road
Tarrytown NY 10591
Svp Research And Development S No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-13 63,234 $8.50 122,355 No 4 M Direct
Common Stock Disposition 2012-02-13 4,741 $113.35 117,614 No 4 F Direct
Common Stock Disposition 2012-02-13 28,869 $113.35 88,745 No 4 F Direct
Common Stock Acquisiton 2012-02-13 3,432 $8.50 92,177 No 4 M Direct
Common Stock Disposition 2012-02-13 257 $113.35 91,920 No 4 F Direct
Common Stock Disposition 2012-02-13 1,597 $113.35 90,323 No 4 F Direct
Common Stock Acquisiton 2012-02-14 50,000 $16.80 140,323 No 4 M Direct
Common Stock Disposition 2012-02-14 7,566 $111.01 132,757 No 4 F Direct
Common Stock Disposition 2012-02-14 21,352 $111.01 111,405 No 4 F Direct
Common Stock Disposition 2012-02-14 333 $107.83 111,072 No 4 S Direct
Common Stock Disposition 2012-02-14 2,350 $108.60 108,722 No 4 S Direct
Common Stock Disposition 2012-02-14 8,510 $109.61 100,212 No 4 S Direct
Common Stock Disposition 2012-02-14 17,694 $110.35 82,518 No 4 S Direct
Common Stock Disposition 2012-02-14 600 $111.91 81,918 No 4 S Direct
Common Stock Disposition 2012-02-14 1,115 $112.10 80,803 No 4 S Direct
Common Stock Disposition 2012-02-14 600 $113.47 80,203 No 4 S Direct
Common Stock Disposition 2012-02-15 19,057 $107.79 61,146 No 4 S Direct
Common Stock Disposition 2012-02-15 2,025 $108.09 59,121 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-02-13 63,234 $0.00 63,234 $8.50
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-02-13 3,432 $0.00 3,432 $8.50
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-02-14 50,000 $0.00 50,000 $16.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,432 2012-02-10 2012-12-20 No 4 M Direct
0 2012-02-10 2012-12-20 No 4 M Direct
69,048 2011-12-31 2018-12-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,335 Indirect By 401(k) Plan
Footnotes
  1. Represents volume-weighted average price of sales of 333 shares of Company stock on February 14, 2012 at prices ranging from $107.62 to $107.96.. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
  2. Represents volume-weighted average price of sales of 2,350 shares of Company stock on February 14, 2012 at prices ranging from $108.03 to $108.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
  3. Represents volume-weighted average price of sales of 8,510 shares of Company stock on February 14, 2012 at prices ranging from $109.02 to $109.98.. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
  4. Represents volume-weighted average price of sales of 17,694 shares of Company stock on February 14, 2012 at prices ranging from $110.00 to $110.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
  5. Represents volume-weighted average price of sales of 600 shares of Company stock on February 14, 2012 at prices ranging from $111.79 to $111.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
  6. Represents volume-weighted average price of sales of 1,115 shares of Company stock on February 14, 2012 at prices ranging from $112.00 to $112.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
  7. Represents volume-weighted average price of sales of 600 shares of Company stock on February 14, 2012 at prices ranging from $113.25 to $113.47. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price.
  8. Represents volume-weighted average price of sales of 19,057 shares of Company stock on February 15, 2012 at prices ranging from $107.60 to $107.98 . Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2012 at each separate price.
  9. Represents volume-weighted average price of sales of 2,025 shares of Company stock on February 15, 2012 at prices ranging from $108.00 to $108.09 . Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2012 at each separate price.
  10. The option became exercisable with respect to all shares underlying the option upon the satisfaction by the company of certain performance criteria on February 10, 2012.
  11. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
  12. The option became exercisable with respect to all shares underlying the option on December 31, 2011, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2011.